This inventor holds 1 USPTO granted patent. Top assignees: Fcb-Pharmicell Co., Ltd., Lifecord Inc., Corp., Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 4 
1 out of 834,708 Years Active: 2008
Title: Hugh-Chul Kim: Innovator in Immunotherapy
Introduction
Hugh-Chul Kim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of immunotherapy through his innovative research and patents. His work focuses on the production of lymphoid dendritic cells, which play a crucial role in various therapeutic applications.
Latest Patents
Hugh-Chul Kim holds 1 patent related to his research. His patent describes a method for producing lymphoid dendritic cells with the immunophenotype CD8α. This method involves culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by culturing in a medium containing IFN-α. The lymphoid dendritic cells produced through this method are valuable for various immunotherapies.
Career Highlights
Throughout his career, Hugh-Chul Kim has worked with several prominent companies in the biotechnology sector. He has been associated with Lifecord Inc. and Fcb-Pharmicell Co., Ltd., where he has contributed to advancing research in immunotherapy and cell production.
Collaborations
Hugh-Chul Kim has collaborated with notable colleagues, including Hyun-Soo Kim and Kyung-Bock Lee. Their joint efforts have furthered the understanding and application of dendritic cell therapies.
Conclusion
Hugh-Chul Kim's innovative work in the field of immunotherapy highlights his commitment to advancing medical science. His contributions through patents and collaborations continue to impact the development of effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile